Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain
Marc P. Baggelaar, Mauro Maccarrone, Mario van der Stelt
Progress in Lipid Research (2018) Vol. 71, pp. 1-17
Open Access | Times Cited: 188

Showing 1-25 of 188 citing articles:

Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders
Daniel Friedman, Jacqueline A. French, Mauro Maccarrone
The Lancet Neurology (2019) Vol. 18, Iss. 5, pp. 504-512
Closed Access | Times Cited: 185
Fluorescent dyes based on rhodamine derivatives for bioimaging and therapeutics: recent progress, challenges, and prospects
Shuang Zeng, Xiaosheng Liu, Yves S. Kafuti, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 16, pp. 5607-5651
Closed Access | Times Cited: 145
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 83
Futile lipid cycling: from biochemistry to physiology
Anand K. Sharma, Radhika Khandelwal, Christian Wolfrum
Nature Metabolism (2024) Vol. 6, Iss. 5, pp. 808-824
Closed Access | Times Cited: 18
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders
Hui Deng, Weimin Li
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 4, pp. 582-602
Open Access | Times Cited: 138
CDP-Diacylglycerol Synthases (CDS): Gateway to Phosphatidylinositol and Cardiolipin Synthesis
Nicholas J. Blunsom, Shamshad Cockcroft
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 89
Cannabimimetic plants: are they new cannabinoidergic modulators?
Amit Kumar, Marika Premoli, Francesca Aria, et al.
Planta (2019) Vol. 249, Iss. 6, pp. 1681-1694
Closed Access | Times Cited: 88
The role of n-3 PUFA-derived fatty acid derivatives and their oxygenated metabolites in the modulation of inflammation
Ian de Bus, Renger F. Witkamp, Han Zuilhof, et al.
Prostaglandins & Other Lipid Mediators (2019) Vol. 144, pp. 106351-106351
Closed Access | Times Cited: 87
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
Noëlle van Egmond, Verena M. Straub, Mario van der Stelt
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 441-463
Open Access | Times Cited: 78
Missing Pieces to the Endocannabinoid Puzzle
Mauro Maccarrone
Trends in Molecular Medicine (2019) Vol. 26, Iss. 3, pp. 263-272
Closed Access | Times Cited: 76
Disorders of cancer metabolism: The therapeutic potential of cannabinoids
Dingya Sun, Xin Li, Shengdan Nie, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113993-113993
Open Access | Times Cited: 63
Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
A.M. Martins, Ana Luísa Gomes, Inês Vilas Boas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 210-210
Open Access | Times Cited: 53
Overexpression of GPX4 attenuates cognitive dysfunction through inhibiting hippocampus ferroptosis and neuroinflammation after traumatic brain injury
Jiang Fang, Qiang Yuan, Zhuoying Du, et al.
Free Radical Biology and Medicine (2023) Vol. 204, pp. 68-81
Closed Access | Times Cited: 34
Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases
Chu Chen
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108394-108394
Open Access | Times Cited: 26
The Effects of Cannabinoids on Ischemic Stroke-Associated Neuroinflammation: A Systematic Review
Eman A. Alraddadi, Faisal F. Aljuhani, Ghadah Y. Alsamiri, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors
Siyu Ren, Zhen‐Zhen Wang, Yi Zhang, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 10, pp. 1263-1271
Open Access | Times Cited: 66
Intake of arachidonic acid-containing lipids in adult humans: dietary surveys and clinical trials
Hiroshi Kawashima
Lipids in Health and Disease (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 57
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
Leontina Elena Filipiuc, Daniela Carmen Ababei, Teodora Alexa‐Stratulat, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1823-1823
Open Access | Times Cited: 53
A large-scale genome–lipid association map guides lipid identification
Vanessa Linke, Katherine A. Overmyer, Ian Miller, et al.
Nature Metabolism (2020) Vol. 2, Iss. 10, pp. 1149-1162
Open Access | Times Cited: 51
Peroxisome proliferator-activated receptor-γ ameliorates neuronal ferroptosis after traumatic brain injury in mice by inhibiting cyclooxygenase-2
Hui Liang, Ting Tang, Han-Yu Huang, et al.
Experimental Neurology (2022) Vol. 354, pp. 114100-114100
Closed Access | Times Cited: 35
Population-level variation in enhancer expression identifies disease mechanisms in the human brain
Pengfei Dong, Gabriel E. Hoffman, Pasha Apontes, et al.
Nature Genetics (2022) Vol. 54, Iss. 10, pp. 1493-1503
Open Access | Times Cited: 35
Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia
Gerwyn Morris, Luba Sominsky, Kenneth R. Walder, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3485-3503
Closed Access | Times Cited: 30
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Alessandro Papa, Silvia Pasquini, Chiara Contri, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 471-471
Open Access | Times Cited: 29
High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue
Eline N. Kuipers, Vasudev Kantae, Boukje C. Eveleens Maarse, et al.
Frontiers in Physiology (2019) Vol. 9
Open Access | Times Cited: 50
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Gerwyn Morris, Ken Walder, Stefan Kloiber, et al.
Pharmacological Research (2021) Vol. 170, pp. 105729-105729
Closed Access | Times Cited: 32
Page 1 - Next Page

Scroll to top